Identification of new modulator of DNA repairing pathways based on natural product (±)-peharmaline A

Area of Science:

• Natural Product Chemistry
• Medicinal Chemistry
• Cancer Biology

Background:

• Tumor heterogeneity drives drug resistance and chemoinsensitivity, leading to more aggressive cancer phenotypes.
• Existing DNA-damaging chemotherapy agents often face limitations due to acquired chemoresistance.
• The natural product (±)-peharmaline A exhibits promising cytotoxic activity against cancer cells.

Purpose of the Study:

• To design and synthesize novel, simplified analogues of (±)-peharmaline A.
• To evaluate the cytotoxic potential of these analogues against cancer.
• To identify lead compounds with enhanced anticancer efficacy compared to the parent natural product.

Main Methods:

• Synthesis of a library of simplified analogues based on the (±)-peharmaline A scaffold.
• In vitro assessment of cytotoxic activities of synthesized compounds.
• Further investigation of a lead demethoxy analogue for its anticancer mechanisms.

Main Results:

• Identification of three structurally simplified analogues with improved potency over (±)-peharmaline A.
• The demethoxy analogue demonstrated significant anticancer potential.
• This analogue acts as a potent DNA-damage inducing agent, reducing DNA repair protein expression.

Conclusions:

• Structurally simplified analogues of (±)-peharmaline A can overcome limitations of the parent compound.
• The demethoxy analogue is a promising candidate for further anticancer drug development.
• The demethoxy analogue's mechanism involves potent DNA damage induction and interference with DNA repair pathways.